Protective effect of neoglycoprotein-Conjugated muramyl dipeptide against leishmania donovani infection: The role of cytokines

Journal of Immunology

Volumn 158, Issue 11, 1997, Pages 5357-5365

  Sarkar, Kakali ^a   Das, Pijush K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; GLYCOPROTEIN; IMMUNOLOGICAL ADJUVANT; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL CULTURE; CELLULAR IMMUNITY; DRUG EFFECT; HUMAN; IMMUNOLOGY; LEISHMANIA DONOVANI; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; VISCERAL LEISHMANIASIS;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELLS, CULTURED; DRUG CARRIERS; GLYCOPROTEINS; HUMANS; IMMUNITY, CELLULAR; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C;

EID: 0031154584     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.158.11.5357     Document Type: Article

References (27)

1. Chang, K. P., and D. M. Dwyer. 1976. Multiplication of human parasite Leishmania donovani in the phagolysosomes of hamster macrophages in vitro. Science 193:678.
2. Garnham, P. C. C., and J. H. Humphrey. 1969. Problems in leishmaniasis related to immunology. Curr. Top. Microbiol. Immunol. 48:29.
3. Skov, C. B., and D. W. Twohy. 1974. Cellular immunity to Leishmania donovani. I. The effect of T cell depletion on resistance to L. donovani in mice. J. Immunol. 113:2004.
4. Skov, C. B., and D. W. Twohy. 1974. Cellular immunity to Leishmania donovani. II. Evidence for synergy between thymocytes and lymph node cells in reconstitution of acquired resistance to L. donovani in mice. J. Immunol. 113:2012.
5. Murray, H. W., J. J. Stern, K. Welte, B. Y. Rubin, S. M. Carriero, and C. F. Nathan. 1987. Experimental visceral leishmaniasis: production of interleukin-2 and interferon-γ, tissue immune reaction, and response to treatment with interleukin-2 and interferon-γ. J. Immunol. 138:2290.
6. Carvalho, E. M., R. S. Teixeira, and W. D. Johnson, Jr. 1981. Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infect. Immun. 33:498.
7. Ho, M., D. K. Koech, D. W. Jha, and D. M. Bryceson. 1983. Immunosuppression in Kenyan visceral leishmaniasis. Clin. Exp. Immunol. 51:207.
8. Blackwell, J. M., and O. M. Ulczak. 1984. Immunoregulation of genetically controlled acquired responses to Leishmania donovani infection in mice: demonstration and characterization of suppressor T cells in noncure mice. Infect. Immun. 44:97.
9. Bloom, B. R. 1979. Games parasites play: how parasites evade immune surveillance. Nature 279:21.
10. Adam, A., J. F. Petit, P. Lefrancier, and E. Lederer. 1981. Muramyl peptides: chemical structure, biological activity and mechanism of action. Mol. Cell Biochem. 41:27.
11. Adam, A., and E. Lederer. 1984. Muramyl peptides: immunomodulators, sleep factors and vitamins. Med. Res. Rev. 4:111.
12. Silverman, D. H. S., H. Wu, and M. L. Karnovsky. 1985. Muramyl peptides and serotonin interact at specific binding sites on macrophages and enhance superoxide release. Biochem. Biophys. Res. Commun. 131:1160.
13. Silverman, D. H. S., J. M. Krueger, and M. L. Karnovsky. 1986. Specific binding sites for muramyl peptides on murine macrophages. J. Immunol. 136:2195.
14. Tenu, J. P., A. C. Roche, A. Yapo, C. Kieda, M. Monsigny, and J. P. Petit. 1982. Absence of cell surface receptors for muramyl peptides in mouse peritoneal macrophages. Biol. Cell 44:157.
15. Fogler, W. E., and I. J. Fidler. 1986. The activation of tumoricidal properties in human blood monocytes by muramyl peptide requires specific cellular interaction. J. Immunol. 136:2311.
16. Taniyama, T., and H. T. Holden. 1979. Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide. Cell. Immunol. 48:369.
17. Phillips, N. C., G. M. Bahr, F. Z. Modabber, and L. Chedid. 1984. Modulation of the growth of murine thymoma cell lines having different Lyt-phenotypes by MDP and MDP (D-D): macrophage-mediated inhibition of in vitro cell growth. Int. J. Immunopharmacol. 6:577.
18. 14C labeled) in the mouse. Int. J. Immunopharmacol. 1:35.
19. Daemen, T., A. Veninga, F. H. Roerdink, and G. L. Scherphof. 1986. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide. Cancer Res. 46:4330.
20. Phillips, N. C., J. Rioux, and M. S. Tsao. 1988. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide. Hepatology 8:1046.
21. Sone, S. 1989. Human monocyte activation to the tumoricidal state by liposome-encapsulated muramyl tripeptide and its therapeutic implication. In Liposomes in the Therapy of Infectious Diseases and Cancer. G. Lopez-Berestein and I. J. Fidler, eds. Alan R. Liss, Inc., New York, p. 125.
22. Dukor, P., and G. Schumann. 1987. Modulation of non-specific resistance by MTP. PE. In Immunopharmacology of Infectious Diseases: Vaccine Adjuvants and Modulators of Non-Specific Resistance of Infectious Diseases. J. A. Majde, ed. Alan R. Liss, Inc., New York, p. 255.
23. Gangemi, J. D., M. Nachtigal, D. Barnhart, L. Krech, and P. Jani. 1987. Therapeutic efficacy of liposome-encapsulated ribavirin and muramyl tripeptide in experimental infection with influenza or herpes simplex virus. J. Infect. Dis. 55:510.
24. Koff, W. C., S. D. Showalier, B. Hampar, and I. J. Fidler. 1985. Protection of mice against fatal herpes simplex type 2 infection by liposomes containing muramyl tripeptide. Science 228:495.
25. Melissen, P. M. B., W. van Vianen, Y. Rijsbergen, and I. A. J. M. Bakker-Woudenberg. 1992. Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide in treatment of experimental Klebsiella pneumoniae infection. Infect. Immun. 60:95.
26. Phillips, N. C., L. Chedid, M. Level, and P. Lefrancier. 1987. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs. J. Biol. Response Modif. 6:678.
27. Basu, N., R. Sett, and P. K. Das. 1991. Down regulation of mannose receptors on macrophages after infection with Leishmania donovani. Biochem. J. 277:451.